Discuss the current system of prescription drug pricing, including industry members such as drug makers, insurance companies, pharmacy benefit managers (PBMs), distributors, pharmacies, etc.
Describe how the Blueprint Policy may affect employers’ group health plans in light of the Blueprint Policy’s goals to create incentives for pharmaceutical companies to lower list prices and reduce consumer out-of-pocket spending at the pharmacy and other care settings.
Discuss whether employers should consider changing their prescription drug plan design in light of potential proposals to increase price transparency, apply a substantial portion of rebates at the point of sale, have a site neutral payment policy for drug administration procedures, have PBMs act solely in the interest of the employer (or consumer) for whom they are managing pharmaceutical benefits, restrict the use of rebates, or prohibit contracted pharmacy gag clauses.
Discuss whether employers should consider changing their prescription drug plans to include newer approaches such as indication-based pricing or outcome-based contracts.
This 60-minute intermediate level webinar will help employers understand how the Blueprint Policy may affect their group health plans that provide prescription drug coverage.
This webinar event has been sent for approval by the Human Resource Certification Institute and the Society for Human Resource Management to qualify for 1 recertification credit hour.
This webinar will provide an overview of the Blueprint Policy Statement and how the policy may affect employers’ group health plans.
